Discussing the science of using transfer RNA for protein editing with hC Bioscience’s CEO
Trekk Venture Partners' Brian Gallagher gives an update on the venture market
Rome Therapeutics’ CEO on the science of the 'Dark Genome' and last week’s $72M Series B extension
Generate Biomedicines' Mike Nally on Thursday's $273M Series C and computational drug development
Baird’s Brian Skorney joins BiotechTV in New York for Analyst Thursdays
Moderna’s Head of R&D explains how mRNA is being tested with other emerging cancer modalities
Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
Aisling Capital's Dennis Purcell gives his take on the current state of biotech
Mariana Oncology’s CEO talks about radiopharmaceuticals and last week’s $175M Series B financing
Hearing from experts in biomedical research while touring the Broad Discovery Center
Brent Saunders talks about his priorities for growth at Bausch + Lomb
Discussing Miami as a biotech hub and general biotech sentiment with Dr. Phillip Frost
Nucleate Florida hosts launch event in Wynwood
Caribou Biosciences’ CEO on working toward a pivotal trial in 2nd line LBCL
The next generation of mRNA beyond vaccines with Strand Therapeutics
BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays
Arcellx’s CMO gives an update on their BCMA program at the 2023 CAR-TCR Summit
Cellares’ CEO on building out the Cell Shuttle to automate cell therapy manufacturing
UPenn’s Bruce Levine discusses the progress of CAR-T at the 2023 CAR-TCR Summit
BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress
.png){kind=logo}
